207 related articles for article (PubMed ID: 10557066)
1. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.
Andreeff M; Jiang S; Zhang X; Konopleva M; Estrov Z; Snell VE; Xie Z; Okcu MF; Sanchez-Williams G; Dong J; Estey EH; Champlin RC; Kornblau SM; Reed JC; Zhao S
Leukemia; 1999 Nov; 13(11):1881-92. PubMed ID: 10557066
[TBL] [Abstract][Full Text] [Related]
2. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells.
Konopleva M; Zhao S; Hu W; Jiang S; Snell V; Weidner D; Jackson CE; Zhang X; Champlin R; Estey E; Reed JC; Andreeff M
Br J Haematol; 2002 Aug; 118(2):521-34. PubMed ID: 12139741
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
Bradbury DA; Zhu YM; Russell NH
Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
[TBL] [Abstract][Full Text] [Related]
4. Effect of all-trans retinoic acid on chemotherapy induced apoptosis and down-regulation of Bcl-2 in human myeloid leukaemia CD34 positive cells.
Ahmed N; Laverick L; Sammons J; Baumforth KR; Hassan HT
Leuk Res; 1999 Aug; 23(8):741-9. PubMed ID: 10456672
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic regulation in primitive hematopoietic precursors.
Peters R; Leyvraz S; Perey L
Blood; 1998 Sep; 92(6):2041-52. PubMed ID: 9731062
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.
Hu ZB; Minden MD; McCulloch EA
Leukemia; 1995 Oct; 9(10):1667-73. PubMed ID: 7564507
[TBL] [Abstract][Full Text] [Related]
7. Ratio of bcl-xshort to bcl-xlong is different in good- and poor-prognosis subsets of acute myeloid leukemia.
Deng G; Lane C; Kornblau S; Goodacre A; Snell V; Andreeff M; Deisseroth AB
Mol Med; 1998 Mar; 4(3):158-64. PubMed ID: 9562974
[TBL] [Abstract][Full Text] [Related]
8. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression.
Bradbury DA; Aldington S; Zhu YM; Russell NH
Br J Haematol; 1996 Sep; 94(4):671-5. PubMed ID: 8826891
[TBL] [Abstract][Full Text] [Related]
10. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
van Stijn A; van der Pol MA; Kok A; Bontje PM; Roemen GM; Beelen RH; Ossenkoppele GJ; Schuurhuis GJ
Haematologica; 2003 May; 88(5):497-508. PubMed ID: 12745269
[TBL] [Abstract][Full Text] [Related]
11. p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells.
Zheng A; Mäntymaa P; Säily M; Savolainen E; Vähäkangas K; Koistinen P
Acta Haematol; 2000; 103(3):135-43. PubMed ID: 10940651
[TBL] [Abstract][Full Text] [Related]
12. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML).
Köhler T; Schill C; Deininger MW; Krahl R; Borchert S; Hasenclever D; Leiblein S; Wagner O; Niederwieser D
Leukemia; 2002 Jan; 16(1):22-9. PubMed ID: 11840259
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
[TBL] [Abstract][Full Text] [Related]
14. In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts.
Pisani F; Del Poeta G; Aronica G; Venditti A; Caravita T; Amadori S
Ann Hematol; 1997 Oct; 75(4):145-7. PubMed ID: 9402847
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.
Konopleva M; Konoplev S; Hu W; Zaritskey AY; Afanasiev BV; Andreeff M
Leukemia; 2002 Sep; 16(9):1713-24. PubMed ID: 12200686
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 protein in human myeloid leukaemia cells and its down-regulation during chemotherapy-induced apoptosis.
Ahmed N; Sammons J; Hassan HT
Oncol Rep; 1999; 6(2):403-7. PubMed ID: 10023011
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
[TBL] [Abstract][Full Text] [Related]
19. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
Hu ZB; Minden MD; McCulloch EA
Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
[TBL] [Abstract][Full Text] [Related]
20. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins.
Konopleva M; Tari AM; Estrov Z; Harris D; Xie Z; Zhao S; López-Berestein G; Andreeff M
Blood; 2000 Jun; 95(12):3929-38. PubMed ID: 10845930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
